Paper38916618
Both intra- and peri-tumoral radiomics signatures can be used to predict lymphatic vascular space invasion and lymphatic metastasis positive status from endometrial cancer MR imaging.
Li S and 9 others. Abdom Radiol (NY), 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Both intra- and peri-tumoral radiomics signatures can be used to predict lymphatic vascular space invasion and lymphatic metastasis positive status from endometrial cancer MR imaging. Papers, record 38916618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38916618
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Both intra- and peri-tumoral radiomics signatures can be used to predict lymphatic vascular space invasion and lymphatic metastasis positive status from endometrial cancer MR imaging.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Endometrial Neoplasms | Major topic |
| Lymphatic Metastasis | Major topic |
| Magnetic Resonance Imaging | Major topic |
| Neoplasm Invasiveness | Major topic |
| Humans | |
| Female | |
| Retrospective Studies | |
| Middle Aged | |
| Aged | |
| Adult | |
| Predictive Value of Tests | |
| Lymphatic Vessels | |
| Radiomics |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26049688 | Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials. | Eur J Cancer | 2015 | https://conductscience.org/library/papers/26049688 | PubMed |
| 2 | 24809776 | A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion. | Br J Cancer | 2014 | https://conductscience.org/library/papers/24809776 | PubMed |
| 3 | 34183201 | Artificial intelligence-based radiomics models in endometrial cancer: A systematic review. | Eur J Surg Oncol | 2021 | https://conductscience.org/library/papers/34183201 | PubMed |
| 4 | 29202963 | Diagnosis of deep endometriosis: clinical examination, ultrasonography, magnetic resonance imaging, and other techniques. | Fertil Steril | 2017 | https://conductscience.org/library/papers/29202963 | PubMed |
| 5 | 32060219 | Introduction to Radiomics. | J Nucl Med | 2020 | https://conductscience.org/library/papers/32060219 | PubMed |
| 6 | 33200420 | Whole-Volume Tumor MRI Radiomics for Prognostic Modeling in Endometrial Cancer. | J Magn Reson Imaging | 2021 | https://conductscience.org/library/papers/33200420 | PubMed |
| 7 | 32229081 | Deep Myometrial Infiltration of Endometrial Cancer on MRI: A Radiomics-Powered Machine Learning Pilot Study. | Acad Radiol | 2021 | https://conductscience.org/library/papers/32229081 | PubMed |
| 8 | 35231806 | MRI radiomics: A machine learning approach for the risk stratification of endometrial cancer patients. | Eur J Radiol | 2022 | https://conductscience.org/library/papers/35231806 | PubMed |
| 9 | 36497362 | MRI- and Histologic-Molecular-Based Radio-Genomics Nomogram for Preoperative Assessment of Risk Classes in Endometrial Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36497362 | PubMed |
| 10 | 32315482 | Multiparametric MRI-Based Radiomics Nomogram for Predicting Lymphovascular Space Invasion in Endometrial Carcinoma. | J Magn Reson Imaging | 2020 | https://conductscience.org/library/papers/32315482 | PubMed |
| 11 | 33741266 | MRI-based traditional radiomics and computer-vision nomogram for predicting lymphovascular space invasion in endometrial carcinoma. | Diagn Interv Imaging | 2021 | https://conductscience.org/library/papers/33741266 | PubMed |
| 12 | 35712484 | Radiomics Nomogram in Assisting Lymphadenectomy Decisions by Predicting Lymph Node Metastasis in Early-Stage Endometrial Cancer. | Front Oncol | 2022 | https://conductscience.org/library/papers/35712484 | PubMed |
| 13 | 37542548 | Development and external validation of a clinical-radiomics nomogram for preoperative prediction of LVSI status in patients with endometrial carcinoma. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/37542548 | PubMed |
| 14 | 31649877 | Multiplanar MRI-Based Predictive Model for Preoperative Assessment of Lymph Node Metastasis in Endometrial Cancer. | Front Oncol | 2019 | https://conductscience.org/library/papers/31649877 | PubMed |
| 15 | 35763096 | Preoperative pelvic MRI and 2-[18F]FDG PET/CT for lymph node staging and prognostication in endometrial cancer-time to revisit current imaging guidelines? | Eur Radiol | 2023 | https://conductscience.org/library/papers/35763096 | PubMed |
| 16 | 32749583 | Radiologists with MRI-based radiomics aids to predict the pelvic lymph node metastasis in endometrial cancer: a multicenter study. | Eur Radiol | 2021 | https://conductscience.org/library/papers/32749583 | PubMed |
| 17 | 33585994 | Introducing the Node Reporting and Data System 1.0 (Node-RADS): a concept for standardized assessment of lymph nodes in cancer. | Eur Radiol | 2021 | https://conductscience.org/library/papers/33585994 | PubMed |
| 18 | 32804986 | FeAture Explorer (FAE): A tool for developing and comparing radiomics models. | PLoS One | 2020 | https://conductscience.org/library/papers/32804986 | PubMed |
| 19 | 29092951 | Computational Radiomics System to Decode the Radiographic Phenotype. | Cancer Res | 2017 | https://conductscience.org/library/papers/29092951 | PubMed |
| 20 | 30031057 | Relief-based feature selection: Introduction and review. | J Biomed Inform | 2018 | https://conductscience.org/library/papers/30031057 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42494600 | Intratumoral and peritumoral MRI habitat imaging for differentiating stage IA endometrial cancer from benign endometrial lesions: a multicenter study. | Front Oncol | 2026 | https://conductscience.org/library/papers/42494600 | PubMed |
| 42177597 | Application Value of a nomogram integrating contrast-enhanced CT radiomics and clinical indicators in evaluating lymph node metastasis in pediatric peripheral neuroblastoma. | Cancer Imaging | 2026 | https://conductscience.org/library/papers/42177597 | PubMed |
| 41814280 | Habitat model based on transvaginal ultrasound images for non-invasive prediction of lymphatic vessel interstitial infiltration in endometrial cancer. | World J Surg Oncol | 2026 | https://conductscience.org/library/papers/41814280 | PubMed |
| 40924128 | Radiomics nomogram from multiparametric magnetic resonance imaging for preoperative prediction of substantial lymphovascular space invasion in endometrial cancer. | Abdom Radiol (NY) | 2026 | https://conductscience.org/library/papers/40924128 | PubMed |
| 40395329 | Predicting recurrence risk in endometrial cancer: a multisequence MRI intratumoral and peritumoral radiomics nomogram approach. | Front Oncol | 2025 | https://conductscience.org/library/papers/40395329 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38916618
GET https://conductscience.org/api/papers/v1/38916618/references?page=2